Guangzhou Tongxin Siwei Spectrum Technology Co., Ltd.

Tongxin Siwei Spectrum Technology Co., Ltd. is a high-tech enterprise dedicated to human health. Established in Shenzhen in 2006, it has now celebrated its 11th anniversary. In 2010, the Tongxin sales headquarters was established, with 15 branch companies under it. Its sales network covers Guangdong, Hunan, Beijing, Shandong, and Zhejiang, with over 600 specialty stores and nearly 2,000 sales personnel. In 2013, Hong Kong Tongxin International Group Co., Ltd. was registered in Hong Kong. In 2014, Songsheng Electronic Technology Co., Ltd. was registered in Dongguan. In January 2015, Jitu E-commerce Company, also known as Bihaohuo Mall, was registered in Shenzhen. In May 2015, Nanchang Zichao Biotechnology Co., Ltd. was acquired. In 2016, Hangzhou Bihaohuo Mall and Shenzhen Jitu Travel Company were successively established. In 2017, a strategic cooperation agreement was signed with the Big Health Industry Development Research Center of Beijing Normal University, Zhuhai Campus. Currently, the company's business spans health product production, sales, e-commerce, daily necessities sales, local specialty sales, and tourism. Meanwhile, the company has formed strategic partnerships with the Medical Science and Technology Center, China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Huaxia Xianbao Di'an Tablet (Beijing) Chinese Medicine Research Institute, Shenzhen Zhuoxian Industrial Co., Ltd., Nanchang Tongxin Zichao Bioengineering Co., Ltd., Bioform (Norway), Shenzhen Haomeishui Technology Co., Ltd., Jiangsu Sheyang Haoyue Liyu Products Co., Ltd., Minsheng Pharmaceutical, and Health Element Group. Tongxin Group plans to go public in 2018 and is currently in the pre-IPO phase. According to the headquarters' strategic plan, Guangzhou Tongxin currently has 42 specialty stores, with plans to establish 80-100 stores. Due to business expansion needs, we are now recruiting talents nationwide. Join hands with Tongxin to create brilliance together.